Cellular mechanisms of IL-17-induced blood-brain barrier disruption

FASEB Journal

Volumn 24, Issue 4, 2010, Pages 1023-1034

  Huppert, Jula ^a   Closhen, Dorothea ^a   Croxford, Andrew ^a   White, Robin ^a   Kulig, Paulina ^b   Pietrowski, Eweline ^a   Bechmann, Ingo ^c   Becher, Burkhard ^b   Luhmann, Heiko J ^a   Waisman, Ari ^a   Kuhlmann, Christoph R W ^a,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Multiple sclerosis; Neuroinflammation; Reactive oxygen species

Indexed keywords

CYTOKINE; INTERLEUKIN 17; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE; 1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; AZEPINE DERIVATIVE; ENZYME INHIBITOR; IL17A PROTEIN, MOUSE; MEMBRANE PROTEIN; MYOSIN LIGHT CHAIN KINASE; NAPHTHALENE DERIVATIVE; NEUTRALIZING ANTIBODY; OCCLUDIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CELL VIABILITY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; HELPER CELL; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPINAL CORD; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TIGHT JUNCTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; AZEPINES; BLOOD-BRAIN BARRIER; CELL LINE, TRANSFORMED; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; INTERLEUKIN-17; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MYOSIN-LIGHT-CHAIN KINASE; NADPH OXIDASE; NAPHTHALENES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, HELPER-INDUCER; XANTHINE OXIDASE;

MURINAE; MUS;

EID: 77951636292     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-141978     Document Type: Article

References (41)

1. Frohman, E. M., Racke, M. K., and Raine, C. S. (2006) Multiple sclerosis - the plaque and its pathogenesis. N. Engl. J. Med. 354, 942-955
2. Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee-Eestermans, I. L., Nicolay, K., Dijkstra, C. D., and de Vries, H. E. (2004) Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127, 616-627
3. Prat, A., Biernacki, K., Lavoie, J., Poirier, J., Duquette, P., and Antel, J. P. (2002) Migration of multiple sclerosis lymphocytes through brain endothelium. Arch. Neurol. 59, 391-397.55
4. Wong, D., Prameya, R., and Dorovini-Zis, K. (2007) Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J. Neuroimmunol. 184, 136-148
5. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., and Prat, A. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175
6. Rouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., and Golstein, P. (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445-5456
7. Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Ozenci, V., Fredrikson, S., and Link, H. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5, 101-104 (Pubitemid 29186827)
8. Lubberts, E., Joosten, L. A., Oppers, B., van den Bersselaar, L., Coenen-de Roo, C. J., Kolls, J. K., Schwarzenberger, P., van de Loo, F. A., and van den Berg, W. B. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167, 1004-1013 (Pubitemid 32660858)
9. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., Murphy, E., Sathe, M., Cua, D. J., Kastelein, R. A., and Rennick, D. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316
10. Wong, C. K., Ho, C. Y., Li, E. K., and Lam, C. W. (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9, 589-593
11. Röhn, T. A., Jennings, G. T., Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M., and Bachmann, M. F. (2006) Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36, 2857-2867
12. Uyttenhove, C., and van Snick, J. (2006) Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 36, 2868-2874
13. Koch, M., Ramsaransing, G. S. M., Arutjunyan, A. V., Stepanov, M., Teelken, A., Heersema, D. J., and de Keyser, J. (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J. Neurol. 253, 483-487
14. Kuhlmann, C. R. W., Tamaki, R., Gamerdinger, M., Lessmann, V., Behl, C., Kempski, O. S., and Luhmann, H. J. (2007) Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J. Neurochem. 102, 501-507
15. Lagrange, P., Romero, I. A., Minn, A., and Revest, P. A. (1999) Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic. Biol. Med. 27, 667-672
16. Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., Hendrikx, E. M. L., Döpp, E. D., Dijkstra, C. D., Drukarch, B., and de Vries, H. E. (2006) Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J. Immunol. 177, 2630-2637 (Pubitemid 44201022)
17. Schreibelt, G., van Horssen, J., Haseloff, R. F., Reijerkerk, A., van der Pol, S. M. A., Nieuwenhuizen, O., Krause, E., Blasig, I. E., Dijkstra, C. D., Ronken, E., and de Vries, H. E. (2008) Protective effects of peroxiredoxin-1 at the injured blood-brain barrier. Free Radic. Biol. Med. 45, 256-264
18. Van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., and de Vries, H. E. (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 45, 1729-1737
19. Brown, R. C., Morris, A. P., and O'Neil, R. G. (2007) Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 1130, 17-30
20. Benton, R. L., Maddie, M. A., Worth, C. A., Mahoney, E. T., Hagg, T., and Whittemore, S. R. (2008) Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury. J. Cereb. Blood Flow Metab. 28, 1771-1785
21. Kuhlmann, C. R., Librizzi, L., Closhen, D., Pflanzner, T., Lessmann, V., Pietrzik, C. U., de Curtis, M., and Luhmann, H. J. (2009) Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke 40, 1458-1466
22. Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., and Waisman, A. (2009) IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61-69
23. Minagar, A., and Alexander, J. S. (2003) Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9, 540-549
24. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., and Fugger, L. (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146-155
25. Afonso, P. V., Ozden, S., Prevost, M., Schmitt, C., Seilhean, D., Weksler, B., Couraud, P., Gessain, A., Romero, I. A., and Ceccaldi, P. (2007) Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J. Immunol. 179, 2576-2583
26. Haorah, J., Schall, K., Ramirez, S. H., and Persidsky, Y. (2008) Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: novel mechanism for neurodegeneration associated with alcohol abuse. Glia 56, 78-88
27. Lander, H. M. (1997) An essential role for free radicals and derived species in signal transduction. FASEB J. 11, 118-124 (Pubitemid 27097584)
28. Garcia, J. G., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., and English, D. (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108, 689-701
29. Dudek, S. M., Jacobson, J. R., Chiang, E. T., Birukov, K. G., Wang, P., Zhan, X., and Garcia, J. G. N. (2004) Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J. Biol. Chem. 279, 24692-24700
30. Verin, A. D., Csortos, C., Durbin, S. D., Aydanyan, A., Wang, P., Patterson, C. E., and Garcia, J. G. (2000) Characterization of the protein phosphatase 1 catalytic subunit in endothelium: involvement in contractile responses. J. Cell. Biochem. 79, 113-125
31. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B. G. (2000) Multiple sclerosis. N. Engl. J. Med. 343, 938-952
32. Lucchinetti, C., Brück, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707-717
33. Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., Bouthillier, A., Becher, B., Arbour, N., David, S., Stanimirovic, D., and Prat, A. (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145
34. Reijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., and de Vries, H. E. (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20, 2550-2552
35. H-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350
36. Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., Blasig, I. E., Dijkstra, C. D., Ronken, E., and de Vries, H. E. (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21, 3666-3676
37. Haorah, J., Heilman, D., Knipe, B., Chrastil, J., Leibhart, J., Ghorpade, A., Miller, D. W., and Persidsky, Y. (2005) Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin. Exp. Res. 29, 999-1009
38. Steffen, B. J., Butcher, E. C., and Engelhardt, B. (1994) Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145, 189-201
39. Volk, T., Hensel, M., Schuster, H., and Kox, W. J. (2000) Secretion of MCP-1 and IL-6 by cytokine stimulated production of reactive oxygen species in endothelial cells. Mol. Cell. Biochem. 206, 105-112 (Pubitemid 30246512)
40. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (Pubitemid 43939170)
41. Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., and Gold, R. (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237, 123-130